Mind Scanners

The Outer Zone · 2021 · $16.99 · Adventure · deal grade B

Estimated net residual revenue: $2.4k to $3.6k per month
Opportunity: $4.5k per month at x1.50 dormancy
Estimated lifetime owners: 34.6k
75%% positive across 1455 reviews · 28.5 reviews/month

Why it's flagged

Developer active, last post 3 months ago
Studio active elsewhere (2 titles tracked), so this one may welcome a partner
Last build shipped 4.3 years ago
Last discounted 0 months ago, 10 sales in the last 12 months
Proven demand elasticity: x2.4 review velocity during past deep sales

Analyst notes (AI-assisted)

A narrative-driven indie adventure where you play a psychiatrist in a dystopian surveillance state, diagnosing and treating patients through dialogue and minigame-based procedures.

Mind Scanners has quietly accumulated $146.5k lifetime revenue on modest unit sales (34.6k), achieving 75% positive sentiment and strong narrative hooks that resonate with Papers, Please enthusiasts. The game still earns $3.0k/mo with minimal marketing spend, suggesting untapped potential in revivals, localization, or licensing the distinctive diagnostic-gameplay mechanic to publishers seeking narrative indie IP. However, a single-title studio with no dev communication in 2.9 months and polarizing minigame design limit near-term growth without external investment. Most realistic play: watch.

Risk: Developer silence (2.9 months since last post) and single-title studio status create uncertainty about long-term support and future content.
Risk: Minigame fatigue is a recurring complaint that fragments the audience; some players abandon mid-playthrough despite loving the narrative.
Risk: Low velocity in past 24 months (avg 15 sales/mo, spike in month 22 unexplained) suggests limited organic discovery and reliance on discounting to drive sales.

This case as Markdown · Estimates carry ±30-50%% error per title.